Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Milestone Pharmaceuticals Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 34 | 28 | −6 |
| Shares | 20.3M | 20.1M | −136.2K (−0.7%) |
| Value | $117.4M | $110.8M | −$6.63M (−5.6%) |
New holders (2)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acadian Asset Management LLC | 12,069 | $67.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,566 | $9.00K | 0.00% |
Sold out (8)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Price T Rowe Associates Inc | 267,997 | $1.55M |
| J. Goldman & Co LP | 100,283 | $581.0K |
| California Public Employees Retirement System | 50,100 | $290.0K |
| TD Asset Management Inc | 18,704 | $108.0K |
| Cowen and Company, LLC | 5,166 | $30.0K |
| Sowell Financial Services LLC | 1,440 | $8.00K |
| Wealthcare Advisory Partners LLC | 352 | $2.00K |
| Bank of America Corp | 37 | $0 |